Dossou, A.S.; Mantsch, M.E.; Kapic, A.; Burnett, W.L.; Sabnis, N.; Coffer, J.L.; Berg, R.E.; Fudala, R.; Lacko, A.G.
Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness. Pharmaceutics 2023, 15, 1685.
https://doi.org/10.3390/pharmaceutics15061685
AMA Style
Dossou AS, Mantsch ME, Kapic A, Burnett WL, Sabnis N, Coffer JL, Berg RE, Fudala R, Lacko AG.
Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness. Pharmaceutics. 2023; 15(6):1685.
https://doi.org/10.3390/pharmaceutics15061685
Chicago/Turabian Style
Dossou, Akpedje S., Morgan E. Mantsch, Ammar Kapic, William L. Burnett, Nirupama Sabnis, Jeffery L. Coffer, Rance E. Berg, Rafal Fudala, and Andras G. Lacko.
2023. "Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness" Pharmaceutics 15, no. 6: 1685.
https://doi.org/10.3390/pharmaceutics15061685
APA Style
Dossou, A. S., Mantsch, M. E., Kapic, A., Burnett, W. L., Sabnis, N., Coffer, J. L., Berg, R. E., Fudala, R., & Lacko, A. G.
(2023). Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness. Pharmaceutics, 15(6), 1685.
https://doi.org/10.3390/pharmaceutics15061685